Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis

Human Gene Therapy

Volumn 9, Issue 18, 1998, Pages 2717-2726

  Gallichan, W S ^a   Kafri, Tal ^b   Krahl, Troy ^a   Verma, Inder M ^b   Sarvetnick, Nora ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INSULIN; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; EXPRESSION VECTOR; FEMALE; GENE EXPRESSION; GENETIC TRANSDUCTION; HUMAN IMMUNODEFICIENCY VIRUS; INSULITIS; LENTIVIRINAE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS TRANSPLANTATION; REPORTER GENE;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRUS;

EID: 0032506750     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.18-2717     Document Type: Article

References (64)

1. ANDERSON, J.T., CORNELIUS, J.G., JARPE, A.J., WINTER, W.E., and PECK, A.B. (1993). Insulin dependent diabetes in the NOD mouse model. II. Beta cell destruction in autoimmune diabetes is a Th2 and not a Th1 mediated event. Autoimmunity 15, 113-122.
2. BERMAN, M.A., SANDBORG, C.I., WANG, Z., IMFELD, K.L., ZALDIVAR, F., JR., DADUFALZA, V., and BUCKINGHAM, B.A. (1996). Decreased IL-4 production in new onset type 1 insulin-dependent diabetes mellitus. J. Immunol. 157, 4690-4696.
3. BLOMER, U., NALDINI, L., VERMA, I.M., TRONO, D., and GAGE, F.H. (1996). Applications of gene therapy to the CNS. Hum. Mol. Genet. 5 (spec. issue), 1397-1404.
4. BLOMER, U., NALDINI, L., KAFRI, T., TRONO, D., VERMA, I.M., and GAGE, F.H. (1997). Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. 71, 6641-6649.
5. BRADLEY, L.M., YOSHIMOTO, K., and SWAIN, S.L. (1995). The cytokines IL-4, IFN-gamma, and IL-12 regulate the development of subsets of memory effector helper T cells in vitro. J. Immunol. 155, 1713-1724.
6. CAMERON, M.J., ARREAZA, G.A., ZUCKER, P., CHENSUE, S.W., STRIETER, R.M., CHAKRABARTI, S., and DELOVITCH, T.L. (1997). IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function. J. Immunol. 159, 4686-4692.
7. CAMPBELL, I.L., KAY, T.W., OXBROW, L., and HARRISON, L.C. (1991). Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J. Clin. Invest. 87, 739-742.
8. DANIEL, D., GILL, R.G., SCHLOOT, N., and WEGMANN, D. (1995). Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol. 25, 1056-1062.
9. DEAIZPURUA, H.J., HONEYMAN, M.C., and HARRISON, L.C. (1992). A 64 kDa antigen/glutamic acid decarboxylase (GAD) in fetal pig pro-islets: Co-precipitation with a 38 kDa protein and recognition by T cells in humans at risk for insulin-dependent diabetes. J. Autoimmun. 5, 759-770.
10. DEBRAY-SACHS, M., CARNAUD, C., BOITARD, C., COHEN, H., GRESSER, I., BEDOSSA, P., and BACH, J.F. (1991). Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. J. Autoimmun. 4, 237-248.
11. DENG, S., KETCHUM, R.J., KUCHER, T., WEBER, M., SHAKED, A., NAJI, A., and BRAYMAN, K.L. (1997a). Adenoviral transfection of canine islet xenografts with immunosuppressive cytokine genes abrogates primary nonfunction and prolongs graft survival. Transplant Proc. 29, 770.
12. DENG, S., KETCHUM, R.J., YANG, Z.D., KUCHER, T., WEBER, M., SHAKED, A., NAJI, A., and BRAYMAN, K.L. (1997b). IL-10 and TGF-beta gene transfer to rodent islets: Effect on xenogeneic islet graft survival in naive and B-cell-deficient mice. Transplant. Proc. 29, 2207-2208.
13. EFRAT, S., FEJER, G., BROWNLEE, M., and HORWITZ, M.S. (1995). Prolonged survival of pancreatic islet allografts mediated by adenovirus immunoregulatory transgenes. Proc. Natl. Acad. Sci. U.S.A. 92, 6947-6951.
14. ELIAS, D., MEILIN, A., ABLAMUNITS, V., BIRK, O.S., CARMI, P., KONEN-WAISMAN, S., and COHEN, I.R. (1997). Hsp60 peptide therapy of NOD mouse diabetes induces a Th2 cytokine burst and downregulates autoimmunity to various β-cell antigens. Diabetes 46, 758-764.
15. FOX, C.J., and DANSKA, J.S. (1997). IL-4 expression at the onset of islet inflammation predicts nondestructive insulitis in nonobese diabetic mice. J. Immunol. 158, 2414-2424.
16. GAINER, A.L., KORBUTT, G.S., RAJOTTE, R.V., WARNOCK, G.L., and ELLIOTT, J.F. (1997). Expression of CTLA4-Ig by biolistically transfected mouse islets promotes islet allograft survival. Transplantation 63, 1017-1021.
17. GAINER, A.L., SUAREZ-PINZON, W.L., MIN, W.P., HANCOCK-FRIESEN, C., KORBUTT, G.S., RAJOTTE, R.V., RABINOVITCH, A., WARNOCK, G.L., and ELLIOTT, J.F. (1998). Prolongation of allograft survival of transfected islets expressing human CTLA4-Ig, human soluble Fas ligand or a combination of the two. Transplant. Proc. 30, 534.
18. HEALEY, D., OZEGBE, P., ARDEN, S., CHANDLER, P., HUTTON, J., and COOKE, A. (1995). In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleens of diabetic NOD mice. J. Clin. Invest. 95, 2979-2985.
19. HSIEH, C.S., MACATONIA, S.E., TRIPP, C.S., WOLF, S.F., O'GARRA, A., and MURPHY, K.M. (1993). Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science 260, 547-549.
20. HUNGER, R.E., CARNAUD, C., GARCIA, I., VASSALLI, P., and MUELLER, C. (1997). Prevention of autoimmune diabetes mellitus in NOD mice by transgenic expression of soluble tumor necrosis factor receptor p55. Eur. J. Immunol. 27, 255-261.
21. INOBE, J.I., CHEN, Y., and WEINER, H.L. (1996). In vivo administration of IL-4 induces TGF-β-producing cells and protects animals from experimental autoimmune encephalomyelitis. Ann. N.Y. Acad. Sci. 778, 390-392.
22. KAFRI, T., BLOMER, U., PETERSON, D.A., GAGE, F.H., and VERMA, I.M. (1997). Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nature Genet. 17, 314-317.
23. KATZ, J.D., BENOIST, C., and MATHIS, D. (1995). T helper cell subsets in insulin-dependent diabetes. Science 268, 1185-1188.
24. KAUFMAN, D.L., CLARE-SALZLER, M., TIAN, J., FORSTHUBER, T., TING, G.S., ROBINSON, P., ATKINSON, M.A., SERCARZ, E.E., TOBIN, A.J., and LEHMANN, P.V. (1993). Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature (London) 366, 69-72.
25. KORBUTT, G.S., SMITH, D.K., RAJOTTE, R.V., and ELLIOTT, J.F. (1995). Expression of beta-galactosidase in mouse pancreatic islets by adenoviral-mediated gene transfer. Transplant. Proc. 27, 3414.
26. KORBUTT, G.S., ELLIOTT, J.F., and RAJOTTE, R.V. (1997). Co-transplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression. Diabetes 46, 317-322.
27. LAU, H.T., YU, M., FONTANA, A., and STOECKERT, C.J., JR. (1996). Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 273, 109-112.
28. LE GROS, G., BEN SASSON, S.Z., SEDER, R., FINKELMAN, F.D., and PAUL, W.E. (1990). Generation of interleukin 4 producing cells in vivo and in vitro: IL-2 and IL-4 are required for generation of IL-4 producing cells. J. Exp. Med. 172, 921-929.
29. LIBLAU, R.S., SINGER, S.M., and McDEVITT, H.O. (1995). Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16, 34-38.
30. MIYOCHI, H., TAKAHASHI, M., GAGE, F.H., and VERMA, I.M. (1997). Stable and efficient gene transfer into the retina using an HFV-based lentiviral vector. Proc. Natl. Acad. Sci. U.S.A. 94, 10319-10323.
31. MOSMANN, T.R., and COFFMAN, R.L. (1989). Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145-173.
32. MUELLER, R., KRAHL, T., and SARVETNICK, N. (1996). Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 184, 1093-1099.
33. MUELLER, R., BRADLEY, L.M., KRAHL, T., and SARVETNICK, N. (1997a). Mechanism underlying counterregulation of autoimmune diabetes by IL-4. Immunity 7, 411-418.
34. MUELLER, R., DAVIES, J.D., KRAHL, T., and SARVETNICK, N. (1997b). IL-4 expression by graphs from transgenic mice fails to prevent allograft rejection. J. Immunol. 159, 1599-1603.
35. NALDINI, L., BLOMER, U., FALLAY, P., ORY, D., MULIGAN, R., GAGE, F.H., VERMA, I.M., and TRONO, D. (1996a). In vivo delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267.
36. NALDINI, L., BLOMER, U., GAGE, F.H., TRONO, D., and VERMA, I.M. (1996b). Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl Acad. Sci. U.S.A. 93, 11382-11388.
37. NAVIAUX, R.K., COSTANZI, E., HAAS, M., and VERMA, I.M. (1996). The pCL vector system: Rapid production of helper-free, high-titer, recombinant retroviruses. J. Virol. 70, 5701-5705.
38. PAKALA, S.V., KURRER, M.O., and KATZ, J.D. (1997). T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice. J. Exp. Med. 186, 299-306.
39. PILSTROM, B., BJORK, L., and BOHME, J. (1995). Demonstration of a Th1 cytokine profile in the late phase of NOD insulitis. Cytokine 7, 806-814.
40. PLOIX, C., BERGEROT, I., FABIEN, N., PERCHE, S., MOULIN, V., and THIVOLET, C. (1998). Protection against autoimmune diabetes with oral insulin is associated with the presence of IL-4 type 2 T-cells in the pancreas and pancreatic lymph nodes. Diabetes 47, 39-44.
41. RABINOVITCH, A., SUAREZ-PINZON, W., EL-SHEIKH, A., SORENSEN, O., and POWER, R.F. (1996). Cytokine gene expression in pancreatic islet-infiltrating leukocytes of BB rats. Expression of Th1 cytokines correlates with β-cell destructive insulitis and IDDM. Diabetes 45, 749-754.
42. RAPOPORT, M.J., JARAMILLO, A., ZIPRIS, D., LAZARUS, A.H., SERREZE, D.V., LEITER, E.H., CYOPICK, P., DANSKA, J.S., and DELOVITCH, T.L. (1993). Interleukin 4 reverses T cell proliferative responsiveness and prevents the onset of diabetes in non-obese diabetic mice. J. Exp. Med. 178, 87-99.
43. SCHARFMANN, R., AXELROD, J.H., and VERMA, I.M. (1991). Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc. Natl. Acad. Sci. U.S.A. 88, 4626-4630.
44. SHAW, M.K., LORENS, J.B., DHAWAN, A., DALCANTO, R., TSE, Y.H., TRAN, A.B., BONPANE, C., ESWARAN, S.L., BROCKE, S., SARVETNICK, N., STEINMAN, L., NOLAN, G.P., and FATHMAN, C.G. (1997). Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J. Exp. Med. 185, 1711-1714.
45. SHEHADEH, N.G., LAROSA, F., and LAFFERTY, K.J. (1993). Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmun. 6, 291-300.
46. SHIMADA, A., ROHANE, P., FATHMAN, C.G., and CHARLTON, B. (1996). Pathogenic and protective roles of CD45Blow CD4+ cells correlate with cytokine profiles in the spontaneously autoimmune diabetic mouse. Diabetes 45, 71-78.
47. SMITH, D.K., KORBUTT, G.S., SUAREZ-PINZON, W.L., KAO, D., RAJOTTE, R.V., and ELLIOTT, J.F. (1997). Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent beta cell destruction in diabetic NOD mice. Transplantation 64, 1040-1049.
48. SWAIN, S.L., WEINBERG, A.D., ENGLISH, M., and HUSTON, G. (1990). EL-4 directs the development of different subsets of helper T cells. J. Immunol. 145, 3796.
49. TIAN, J., CLARE-SALZLER, M., HERSCHENFELD, A., MIDDLETON, B., NEWMAN, D., MUELLER, R., ARITA, S., EVANS, C., ATKINSON, M.A., MULLEN, Y., SARVETNICK, N., TOBIN, A.J., LEHMANN, P.V., and KAUFMAN, D.L. (1996). Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice. Nature Med. 2, 1348-1353.
50. TIAN, J., LEHMANN, P.V., and KAUFMAN, D.L. (1997). Determinant spreading of T helper cell 2 (Th2) responses to pancreatic islet autoantigens. J. Exp. Med. 186, 2039-2043.
51. TIAN, J., CHAU, C., and KAUFMAN, D.L. (1998). Insulin selectively primes Th2 responses and induces regulatory tolerance to insulin in pre-diabetic mice. Diabetologia 41, 237-240.
52. TISCH, R., YANG, X.D., SINGER, S.M., LIBLAU, R.S., FUGGER, L., and McDEVITT, H.O. (1993). Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature (London) 366, 72-75.
53. TOMINAGA, Y., NAGATA, M., YASUDA, H., OKAMOTO, N., ARISAWA, K., MORIYAMA, H., MIKI, M., YOKONO, K., and KASUGA, M. (1998). Administration of EL-4 prevents autoimmune diabetes but enhances pancreatic insulitis in NOD mice. Clin. Immunol. Immunopathol. 86, 209-218.
54. VERMA, I.M., and SOMIA, N. (1997). Gene therapy - promises, problems and prospects. Nature (London) 389, 239-242.
55. VON HERRATH, M.G., and OLDSTONE, B.A. (1997a). Interferon-γ is essential for destruction of β-cells and development of insulin-dependent diabetes mellitus. J. Exp. Med. 185, 531-539.
56. VON HERRATH, M.G., EFRAT, S., OLDSTONE, M.B., and HORWITZ, M.S. (1997b). Expression of adenoviral E3 transgenes in beta cells prevents autoimmune diabetes. Proc. Natl. Acad. Sci. U.S.A. 94, 9808-9813.
57. WANG, B., ANDRE, I., GONZALEZ, A., KATZ, J.D., AGUET, M., BENOIST, C., and MATHIS, D. (1997). Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes. Proc. Natl. Acad. Sci. U.S.A. 94, 13844-13849.
58. WEIR, G.C., and BONNER-WEIR, S. (1997). Scientific and political implediments to successful islet transplantation. Diabetes 46, 1247-1256.
59. WELSH, N., BENDTZEN, K., and WELSH, M. (1995). Expression of an insulin/interleukin-1 receptor antagonist hybrid gene in insulin-producing cell lines. (HIT-T15 and NIT-1 ) confers resistance against interleukin-1-induced nitric oxide production. J. Clin. Invest. 95, 1717-1722.
60. WICKER, L.S., MILLER, B.J., and MULLEN, Y. (1986). Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes 35, 855-860.
61. WILSON, S.B., KENT, S.C., PATTON, K.T., ORBAN, T., JACKSON, R.A., EXLEY, M., PORCELLI, S., SCHATZ, D.A., ATKINSON, M.A., BALK, S.P., STROMINGER, J.L., and HAFLER, D.A. (1998). Extreme Th1 bias of invariant Va24JaQ T cells in type 1 diabetes. Nature (London) 391, 177-181.
62. YOON, J.W., JUN, H.S., and SANTAMARIA, P. (1998). Cellular and molecular mechanisms for the initiation and progression of beta cell destruction resulting from the collaboration between macrophages and T cells. Autoimmunity 27, 109-122.
63. YOSHIMOTO, K., SWAIN, S.L., and BRADLEY, L.M. (1996). Enhanced development of Th2-like primary CD4 effectors in response to sustained exposure to limited rBL-4 in vivo. J. Immunol. 156, 3267-3274.
64. ZEKZER, D., WONG, F.S., AYALON, O., MILLET, I., ALTIERI, M., SHINTANI, S., SOLIMENA, M., and SHERWIN, R.S. (1998). GAD-reactive CD4+ Th1 cells induce diabetes in NOD/SCID mice. J. Clin. Invest. 101, 67-73.